Novo Nordisk Shares Drop 10% After New Weight-Loss Drug Announcement

Shares of the Danish pharmaceutical company Novo Nordisk fell significantly after announcing the development of a new drug for weight loss. Investors reacted cautiously, awaiting confirmation of the drug's efficacy.

Shares of Novo Nordisk fell 10% on Monday after the company announced its new weight-loss drug. The new medication has generated significant interest in the pharmaceutical market. Investors reacted to the news with a sharp drop in share prices. Analysts attribute this to uncertainty about the effectiveness of the new drug. The company plans to release more data in the near future.

Latest news

See all news

2026-02-15T04:18:53+00:00

Cancer Diagnosis Increases Crime Likelihood by 14%

A new study in Denmark has revealed a stunning link: a cancer diagnosis increases the likelihood of committing a crime by 14%. Researchers found that financial hardship and the psychological shock of an incurable diagnosis push people, even those with a clean record, to break the law, as the threat of future punishment loses its meaning.

Health Economy Politics Country

2026-02-06T04:32:13+00:00

Weight-loss drugs change shopper habits

A study by Danish scientists showed that taking GLP-1 agonists affects food choices. Users started buying fewer high-calorie foods and sugars, preferring proteins and unprocessed products.

Health Country

2026-02-03T19:25:50+00:00

Novo Nordisk shares fall 14% on profit growth forecast

Shares of pharmaceutical giant Novo Nordisk plummeted 14% on Tuesday after the company announced a forecast for lower sales and profit growth this year. Investors reacted to the news with a sharp drop in stock prices.

Economy Health Country

2026-01-20T13:19:43+00:00

Philippines Embassy Monitors Greenland Situation

The Philippine Embassy in Denmark urged Filipinos in Greenland to stay calm and rely only on official information sources. Authorities are updating a citizen directory for timely communication.

Politics Health Country